Mackenzie Financial
BEAM icon

Mackenzie Financial’s Beam Therapeutics BEAM Stock Holding History

Mackenzie Financial’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.37M Buy
+185,499
New +$5.6M 0.01% 773
2022
Q1 		– Sell
-2,644
Closed -$211K – 1415
2021
Q4 		$211K Sell
2,644
-112
-4% -$9.59K ﹤0.01% 1314
2021
Q3 		$240K Buy
2,756
+1,103
+67% +$111K ﹤0.01% 1231
2021
Q2 		$213K Buy
+1,653
New +$132K ﹤0.01% 1156

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Mackenzie Financial's BEAM Position: Q2 2026 in Review

Mackenzie Financial opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 185,499 shares worth $6.37M. The stake represents 0.01% of the portfolio and ranks #773 among its holdings. This is a return to the name: Mackenzie Financial previously reported a position in BEAM as recently as Q4 2021.

Mackenzie Financial first reported a position in BEAM in Q2 2021 and has held it in 4 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Mackenzie Financial held 185,499 shares of Beam Therapeutics worth $6.37M as of Q2 2026.
  • Beam Therapeutics was a new Mackenzie Financial position in Q2 2026.
  • Beam Therapeutics made up 0.01% of Mackenzie Financial's portfolio in Q2 2026, its #773 holding.
  • Mackenzie Financial first reported a position in Beam Therapeutics in Q2 2021 and has held it in 4 quarters since.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.